French president: COVID vaccine appears 'quasi-ineffective' on elderly patients
Vaccine 'doesn't work the way we were expecting it to' on older individuals, he said.
The Facts Inside Our Reporter’s Notebook
French President Emmanuel Macron claimed on Friday that the AstraZeneca COVID-19 vaccine appears to have little effect on elderly patients, though a major European medical authority said the data in that regard was too limited to yet make an ultimate determination.
Macron told reporters that AstraZeneca's vaccine "doesn't work the way we were expecting it to," and that the injection appears "quasi-ineffective on people older than 65, some say those 60 years or older."
Macron noted that France was still waiting on data from the European Union's European Medicines Agency to guide its vaccination policy; the EMA later in the day deemed the vaccine safe for all adults.
"There are not yet enough results in older participants (over 55 years old) to provide a figure for how well the vaccine will work in this group," the EMA said in a statement. "However, protection is expected, given that an immune response is seen in this age group and based on experience with other vaccines."
News, not Noise
- Arizona audit flags thousands of suspect ballots, kicking issue to state's attorney general
- Effort to spread discredited Russia collusion theory welcomed by McCain Senate panel, memos show
- Lawsuits filed in Washington state over 2020 election
- DeSantis sidesteps Biden rationing, acquires new monoclonal antibodies from U.K. drug firm
- Draft report of Maricopa audit finds Biden won but flags as many as 44,000 votes as 'critical'